◼ Archived
Business
🔮 fades ✓
Roche Drug Candidate Hits Target in Late-Stage Study for Autoimmune Disease
Roche's Sefaxersen hits target in late-stage study for autoimmune disease
Phase 3
6 independently detected trends connected to this subject, with the latest coverage first.
What Archynetys tracks about Phase 3
This hub groups 6 separate news trends connected to Phase 3, spanning July 22, 2026 through September 23, 2026. Each event page combines source coverage, attention velocity and a time-stamped explanation instead of treating every headline as a separate story.
The record below represents 48 article observations and 45 source signals, led by Business coverage. Use it to compare how individual events emerged, spread and changed over time.
◼ Archived
Business
🔮 fades ✓
Amgen’s Horizon-acquired fusion protein eases Sjögren's severity in ph. 3 win
10 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
Vera kidney drug Trutakna shows strong final results in Phase 3 trial
7 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 holds ✗
Psychedelics Stock, Up 190% This Year, Flies High Again
12 news sources are covering this Business story right now — Archynetys is tracking how fast it spreads.
◼ Archived
Business
🔮 fades ✓
A ‘Transformative’ Narcolepsy Drug Opens New Opportunities in Neuroscience
A new narcolepsy drug clears Phase 3, earning acclaim and prompting talks of a neuroscience breakthrough.
◼ Archived
Business
🔮 fades ✗
The 'Best-Case Scenario' That Shot Arrowhead Stock Sky-High
Arrowhead Pharmaceuticals shares have surged following positive Phase 3 results for its fat-lowering drug plozasiran.